Tags

Type your tag names separated by a space and hit enter

Botulinum toxin type A for Levodopa-induced cervical dyskinesias in Parkinson's disease: unfavorable risk-benefit ratio.
Mov Disord. 2011 Apr; 26(5):913-4.MD

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Letter
Randomized Controlled Trial

Language

eng

PubMed ID

21432906

Citation

Espay, Alberto J., et al. "Botulinum Toxin Type a for Levodopa-induced Cervical Dyskinesias in Parkinson's Disease: Unfavorable Risk-benefit Ratio." Movement Disorders : Official Journal of the Movement Disorder Society, vol. 26, no. 5, 2011, pp. 913-4.
Espay AJ, Vaughan JE, Shukla R, et al. Botulinum toxin type A for Levodopa-induced cervical dyskinesias in Parkinson's disease: unfavorable risk-benefit ratio. Mov Disord. 2011;26(5):913-4.
Espay, A. J., Vaughan, J. E., Shukla, R., Gartner, M., Sahay, A., Revilla, F. J., & Duker, A. P. (2011). Botulinum toxin type A for Levodopa-induced cervical dyskinesias in Parkinson's disease: unfavorable risk-benefit ratio. Movement Disorders : Official Journal of the Movement Disorder Society, 26(5), 913-4. https://doi.org/10.1002/mds.23522
Espay AJ, et al. Botulinum Toxin Type a for Levodopa-induced Cervical Dyskinesias in Parkinson's Disease: Unfavorable Risk-benefit Ratio. Mov Disord. 2011;26(5):913-4. PubMed PMID: 21432906.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Botulinum toxin type A for Levodopa-induced cervical dyskinesias in Parkinson's disease: unfavorable risk-benefit ratio. AU - Espay,Alberto J, AU - Vaughan,Jennifer E, AU - Shukla,Rakesh, AU - Gartner,Maureen, AU - Sahay,Alok, AU - Revilla,Fredy J, AU - Duker,Andrew P, Y1 - 2011/03/22/ PY - 2011/3/25/entrez PY - 2011/3/25/pubmed PY - 2011/8/25/medline SP - 913 EP - 4 JF - Movement disorders : official journal of the Movement Disorder Society JO - Mov Disord VL - 26 IS - 5 SN - 1531-8257 UR - https://www.unboundmedicine.com/medline/citation/21432906/Botulinum_toxin_type_A_for_Levodopa_induced_cervical_dyskinesias_in_Parkinson's_disease:_unfavorable_risk_benefit_ratio_ L2 - https://doi.org/10.1002/mds.23522 DB - PRIME DP - Unbound Medicine ER -